{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:29:30Z","timestamp":1791653370235,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1124\/dmd.117.078915","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T16:35:12Z","timestamp":1517589312000},"page":"458-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties"],"prefix":"10.1016","volume":"46","author":[{"given":"J. Cory","family":"Kalvass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Heinle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjoleen J.M.A.","family":"Nijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.078915_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejps.2004.11.011","article-title":"Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method","volume":"24","author":"Avdeef","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.10332","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1124\/dmd.111.040766","article-title":"Species differences in distribution and prediction of human V(ss) from preclinical data","volume":"39","author":"Berry","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.078915_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/00365515909060460","article-title":"A method for the determination of free, non-protein bound thyroxine in serum","volume":"11","author":"Christensen","year":"1959","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1124\/dmd.117.078915_bib5","doi-asserted-by":"crossref","first-page":"465715","DOI":"10.1155\/2008\/465715","article-title":"Cross-species differential plasma protein binding of MBX-102\/JNJ39659100: a novel PPAR-gamma agonist","volume":"2008","author":"Clarke","year":"2008","journal-title":"PPAR Res"},{"key":"10.1124\/dmd.117.078915_bib6","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.xphs.2017.09.005","article-title":"Industry perspective on contemporary protein-binding methodologies: considerations for regulatory drug-drug interaction and related guidelines on highly bound drugs","volume":"106","author":"Di","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/jps.23013","article-title":"Impact of recovery on fraction unbound using equilibrium dialysis","volume":"101","author":"Di","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2005.01.015","article-title":"Studies of drug binding to plasma proteins using a variant of equilibrium dialysis","volume":"38","author":"Eriksson","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.117.078915_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00563104","article-title":"Pharmacokinetics of quinidine related to plasma protein binding in man","volume":"15","author":"Fremstad","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.117.078915_bib10","first-page":"3248","article-title":"Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein","volume":"58","author":"Fuse","year":"1998","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.117.078915_bib11","unstructured":"Indomethacin. (2016) Package insert. Iroko Pharmaceuticals, LLC, Philadelphia."},{"key":"10.1124\/dmd.117.078915_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.078915_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/dmd.106.012294","article-title":"Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios","volume":"35","author":"Kalvass","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.078915_bib14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jps.2600570939","article-title":"Novel method for studying protein binding","volume":"57","author":"Meyer","year":"1968","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jps.2600590104","article-title":"Dynamic dialysis as a method for studying protein binding. I. Factors affecting the kinetics of dialysis through a cellophane membrane","volume":"59","author":"Meyer","year":"1970","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jps.2600590105","article-title":"Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems","volume":"59","author":"Meyer","year":"1970","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.078915_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1468-1293.2006.00356.x","article-title":"Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions","volume":"7","author":"Motoya","year":"2006","journal-title":"HIV Med"},{"key":"10.1124\/dmd.117.078915_bib18","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/jps.24506","article-title":"Plasma protein binding of challenging compounds","volume":"104","author":"Riccardi","year":"2015","journal-title":"J Pharm Sci"},{"issue":"Suppl 1","key":"10.1124\/dmd.117.078915_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199700321-00004","article-title":"Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers","volume":"32","author":"Ronfeld","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.117.078915_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF01935978","article-title":"A dialysis rate method for the measurement of free iodothyronine and steroid hormones in blood","volume":"34","author":"Ross","year":"1978","journal-title":"Experientia"},{"key":"10.1124\/dmd.117.078915_bib21","unstructured":"U.S. Food and Drug Administration (FDA). Center for Drug Evaluation and Research. Sirturo NDA 204384 Clinical Pharmacology and Biopharmaceutics Review, Section 2.2.5.4, December 10, 2012."},{"key":"10.1124\/dmd.117.078915_bib22","unstructured":"U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Tykerb NDA 22-059 Clinical Pharmacology and Biopharmaceutics Review, Section 2.2.5.4, January 24, 2007."},{"key":"10.1124\/dmd.117.078915_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chroma.2005.10.030","article-title":"High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry","volume":"1102","author":"Wan","year":"2006","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.117.078915_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/aic.690010222","article-title":"Correlation of diffusion coefficients in dilute solutions","volume":"1","author":"Wilke","year":"1955","journal-title":"AIChE J"},{"key":"10.1124\/dmd.117.078915_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpba.2017.03.019","article-title":"Automation of plasma protein binding assay using rapid equilibrium dialysis device and Tecan workstation","volume":"140","author":"Ye","year":"2017","journal-title":"J Pharm Biomed Anal"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.078915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:34:31Z","timestamp":1739903671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624054916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0090955624054916"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.078915","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.078915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}